Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

07.11.2017 | short review | Ausgabe 4/2017 Open Access

memo - Magazine of European Medical Oncology 4/2017

Anti-angiogenic therapies for the treatment of angiosarcoma: a clinical update

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 4/2017
Autoren:
Robin J. Young, Penella J. Woll

Summary

Angiosarcomas are rare aggressive endothelial tumours, and are associated with a poor prognosis. Due to their vascular nature, there is great interest in their response to anti-angiogenic agents. A number of small prospective studies have reported angiosarcoma response to vascular-targeted agents, including agents that target vascular endothelial growth factor. To date, the response to these agents has been disappointing, and similar to the response observed in other soft tissue sarcoma subtypes. This short review will summarise the recent data in this field.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2017

memo - Magazine of European Medical Oncology 4/2017 Zur Ausgabe